BBNX News
Archived Headlines
- Insulin delivery device maker Beta Bionics increases deal size by 47% ahead of $165 million IPO 01/28/25
- US IPO Week Ahead: Meat, oil, and more set to debut in 5 IPO week 01/24/25
- Insulin delivery device maker Beta Bionics sets terms for $113 million IPO 01/22/25
- US IPO Weekly Recap: Flowco launches first major IPO of 2025 as Smithfield, others join the pipeline 01/10/25
- Insulin delivery device maker Beta Bionics files for a $100 million IPO 01/06/25
Updated: Renaissance Capital's 1Q 2025 US IPO Market Review
IPO Pickup Interrupted by Market CorrectionIn the first quarter of 2025, 53 IPOs raised a combined $8.5 billion, after a strong start was cut off by a market correction near quarter end. Both deal count and proceeds increased from the 1Q24, despite concerns...read more
US IPO Weekly Recap: Active January closes out with several sizable IPOs
Five IPOs listed this week, all of which raised over $100 million. One direct listing and three SPACs also debuted. Four IPOs and three SPACs submitted initial filings.Leading meat products producer Smithfield Foods (SFD) priced its downsized IPO below the...read more
Sizable IPO filings reach a three-year high amid steady stream of deals
The 2025 IPO market has kicked off with a steady stream of large deals, and new filing activity signals more to come. Thirteen IPOs planning to raise $100 million or more have joined the pipeline, the most in a single month since January 2022....read more
Insulin delivery device maker Beta Bionics prices further upsized IPO at $17, the high end of the upwardly revised range
Beta Bionics, which makes an automated insulin delivery system for type 1 diabetes, raised $204 million by offering 12 million shares at $17, the high end of the range of $16 to $17. It raised an additional $17 million in a concurrent private placement to an...read more